Prevalence of bipolar disorder in the general population: a Reappraisal Study of the Netherlands Mental Health Survey and Incidence Study

Regeer, Eline J.; Have, M.L. ten; Rosso, Marinela; Roijen, Leona Hakkaart-van; Vollebergh, Wilma; Nolen, Willem A.

doi:10.1111/j.1600-0447.2004.00363.x

Cited by 78 publications

(60 citation statements)

References 24 publications

(26 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The reported lifetime prevalence for bipolar spectrum disorders (Bipolar I, II or NOS) is about 5.5% (Angst 1995;Regeer et al 2004), although slight deviations of these numbers may occur depending on the sample (Merikangas et al 2007). Together with increasing evidence of an underlying genetic aetiology (Hayden and Nurnberger 2006) the relatively uniform epidemiological figures support, without neglecting ethnic and cultural diversity, that an optimised biological, mostly psychopharmacological, treatment may bring comparable benefits across cultures.…”

Section: Introductionmentioning

confidence: 99%

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

Grunze

Vieta

Goodwin

et al. 2009

The World Journal of Biological Psychiatry

318

247

View full text Add to dashboard Cite

These updated guidelines are based on a first edition that was published in 2003, and have been edited and updated with the available scientific evidence until end of 2008. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute mania in adults. The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from the clinical trial database clinicaltrials.gov, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into six levels of evidence (AÁF). As these guidelines are intended for clinical use, the scientific evidence was finally asigned different grades of recommendation to ensure practicability.

show abstract

Section: Introductionmentioning

confidence: 99%

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

Grunze

Vieta

Goodwin

et al. 2009

The World Journal of Biological Psychiatry

318

247

View full text Add to dashboard Cite

show abstract

“…This means that the NCS-R sub-threshold BPD prevalence estimate is likely to be a lower bound estimate, although it is broadly consistent with the results of two large community epidemiological surveys in Europe. 62,63 Turning now to prevalence estimates for working people, 12-month prevalence estimates of MDD and BPD among working NCS-R respondents are somewhat lower than in the total sample: 6.4% for MDD and 1.1% for BPD. 7 This pattern is consistent with the finding in previous surveys that mood disorder is associated with not being in the labor force 64,65 and with the results of controlled intervention studies that treatment of depression is associated with a significant reduction in termination of labor force participation.…”

Section: Prevalencementioning

confidence: 99%

The Prevalence and Correlates of Workplace Depression in the National Comorbidity Survey Replication

Kessler

Merikangas

Wang

2008

Journal of Occupational &Amp; Environmental Medicine

View full text Add to dashboard Cite

show abstract

“…39,40 However, it is likely to be a lower bound because we did not include reduced duration of hypomanic episodes. The NCS-R results clearly document the clinical significance of subthreshold BPD, as most subthreshold cases had moderate-severe symptom profiles and role impairment based on standard rating scales.…”

Section: Commentmentioning

confidence: 99%

Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication

Merikangas¹,

Akiskal²,

Angst³

et al. 2007

Arch Gen Psychiatry

2,115

1,336

View full text Add to dashboard Cite

Context: There is growing recognition that bipolar disorder (BPD) has a spectrum of expression that is substantially more common than the 1% BP-I prevalence traditionally found in population surveys.Objective: To estimate the prevalence, correlates, and treatment patterns of bipolar spectrum disorder in the US population.Design: Direct interviews.Setting: Households in the continental United States.Participants: A nationally representative sample of 9282 English-speaking adults (aged Ն18 years).Main Outcome Measures: Version 3.0 of the World Health Organization's Composite International Diagnostic Interview, a fully structured lay-administered diagnostic interview, was used to assess DSM-IV lifetime and 12-month Axis I disorders. Subthreshold BPD was defined as recurrent hypomania without a major depressive episode or with fewer symptoms than required for threshold hypomania. Indicators of clinical severity included age at onset, chronicity, symptom severity, role impairment, comorbidity, and treatment.Results: Lifetime (and 12-month) prevalence estimates are 1.0% (0.6%) for BP-I, 1.1% (0.8%) for BP-II, and 2.4% (1.4%) for subthreshold BPD. Most respondents with threshold and subthreshold BPD had lifetime comorbidity with other Axis I disorders, particularly anxiety disorders. Clinical severity and role impairment are greater for threshold than for subthreshold BPD and for BP-II than for BP-I episodes of major depression, but subthreshold cases still have moderate to severe clinical severity and role impairment. Although most people with BPD receive lifetime professional treatment for emotional problems, use of antimanic medication is uncommon, especially in general medical settings.Conclusions: This study presents the first prevalence estimates of the BPD spectrum in a probability sample of the United States. Subthreshold BPD is common, clinically significant, and underdetected in treatment settings. Inappropriate treatment of BPD is a serious problem in the US population. Explicit criteria are needed to define subthreshold BPD for future clinical and research purposes. Psychiatry. 2007;64:543-552 Arch Gen

show abstract

Prevalence of bipolar disorder in the general population: a Reappraisal Study of the Netherlands Mental Health Survey and Incidence Study

Abstract: Compared with the SCID, the CIDI on the one hand overdiagnoses bipolar disorder but on the other hand underdiagnoses bipolar disorder.

Cited by 78 publications

References 24 publications

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania

The Prevalence and Correlates of Workplace Depression in the National Comorbidity Survey Replication

Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication

Contact Info

Product

Resources

About